Maze Therapeutics, a South San Francisco startup, launched with funding from Third Rock Ventures, ARCH Venture Partners, GV and others, with a goal of identifying genetic modifiers to develop new drugs.
Third Rock And ARCH-Backed Genetics Startup Launches With Nearly $200 Million
